Pulse Therapeutics' Series C Round

Pulse Therapeutics raised a round of funding on January 27, 2016.

Pulse Therapeutics has developed a medical device designed to significantly improve the conveyance of physician-selected agents, like tPA, in the emergency department (ED). By destroying clots earlier…

Articles about Pulse Therapeutics' Series C Round: